Table 3 Cohen’s Kappa showing rater-rater reliability for confidence questions

…managing hypertension as a disease?

…managing hypertension in patients with CKD?

…managing hypertension in patients with CKD with Diabetes?

..that you can achieve lowered blood pressure in patients with CKD?

…interpreting eGFR to stage CKD?

..with monitoring eGFR in patients with CKD?

…monitoring eGFR in CKD patient with Diabetes?

…identifying significant proteinuria in patients with Diabetes?

…identifying significant proteinuria in patients with CKD?

…using urine protein (ACR or PCR) results to manage Diabetes?

…using urine protein (ACR or PCR) results to manage CKD?

…using ACE inhibitors and / or ARB’s?

…using ACE inhibitors and / or ARB’s in patients with CKD?

..using other anti-hypertensives in patients with CKD?

…in adding a loop diuretic drug to patients with CKD (stage 3b and above) already on maximum dose of an ACE inhibitor and/or ARB?

…identifying CVD risk factors for patients with CKD?

…assessing CVD risk scores in patients with Diabetes?

…assessing CVD risk scores in patients with CKD?

…initiating therapy to lower lipid levels in patients with heart disease?

…initiating therapy to lower lipid levels in patients with CKD?

…using referral guidelines to refer appropriate patients with Diabetes (Type 2) to secondary care?

…using referral guidelines to refer appropriate patients with CKD to secondary care?

…the overall management of patients with Diabetes (Type 2)?

…the overall management of patients with CKD?